127 related articles for article (PubMed ID: 15548127)
21. Should we encourage over-the-counter statins? A population perspective for coronary heart disease prevention.
Gemmell I; Verma A; Harrison RA
Am J Cardiovasc Drugs; 2007; 7(4):299-302. PubMed ID: 17696570
[TBL] [Abstract][Full Text] [Related]
22. The Over-the-Counter Medicines Market in Poland.
Lasota D; Mirowska-Guzel D; Goniewicz M
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554903
[TBL] [Abstract][Full Text] [Related]
23. Switching from prescription to over-the counter medications: a consumer and managed care perspective.
Pawaskar MD; Balkrishnan R
Manag Care Interface; 2007 Jan; 20(1):42-7. PubMed ID: 17310652
[TBL] [Abstract][Full Text] [Related]
24. The drugs don't sell: DIY heart health and the over-the-counter statin experience.
Will CM; Weiner K
Soc Sci Med; 2015 Apr; 131():280-8. PubMed ID: 24954520
[TBL] [Abstract][Full Text] [Related]
25. AMCP Partnership Forum: Biosimilars--Ready, Set, Launch.
J Manag Care Spec Pharm; 2016 Apr; 22(4):434-40. PubMed ID: 27023697
[TBL] [Abstract][Full Text] [Related]
26. A 30-month evaluation of the effects on the cost and utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state employee health plan.
West DS; Johnson JT; Hong SH
J Manag Care Pharm; 2006; 12(1):25-32. PubMed ID: 16420105
[TBL] [Abstract][Full Text] [Related]
27. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
28. 'It's all there in black and white' - or is it? Consumer perspectives on the proposed Australian Medicine Information Box over-the-counter label format.
Tong V; Raynor DK; Aslani P
Health Expect; 2016 Aug; 19(4):948-61. PubMed ID: 26230544
[TBL] [Abstract][Full Text] [Related]
29. Assessing the effectiveness of OTC Advertising on artificial tear drops from an experiential marketing perspective.
Gheorghe CM; Purcărea VL; Gheorghe IR
Rom J Ophthalmol; 2019; 63(3):297-305. PubMed ID: 31687635
[No Abstract] [Full Text] [Related]
30. The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database.
Filion KB; Delaney JA; Brophy JM; Ernst P; Suissa S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):1-4. PubMed ID: 16953516
[TBL] [Abstract][Full Text] [Related]
31. The 2009 Health Confidence Survey: public opinion on health reform varies; strong support for insurance market reform and public plan option, mixed response to tax cap.
Fronstin P; Helman R
EBRI Issue Brief; 2009 Jul; (331):1-16. PubMed ID: 19580218
[TBL] [Abstract][Full Text] [Related]
32. Pharmacy students' views of managed care pharmacy and PBMS: should there be more exposure to managed care in the pharmacy curriculum?
Pittenger AL; Starner CI; Thompson K; Gleason PP
J Manag Care Pharm; 2010 Jun; 16(5):346-54. PubMed ID: 20518587
[TBL] [Abstract][Full Text] [Related]
33. Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market.
Håkonsen H; Sundell KA; Martinsson J; Hedenrud T
Health Policy; 2016 Mar; 120(3):327-33. PubMed ID: 26861972
[TBL] [Abstract][Full Text] [Related]
34. Direct-To-Consumer Advertising of Over-the-Counter Sinonasal Remedies: A History of Mixed Messages.
McCoul ED
Laryngoscope; 2020 Sep; 130(9):2114-2119. PubMed ID: 31654426
[TBL] [Abstract][Full Text] [Related]
35. Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy.
Garrison LP; Neumann PJ; Willke RJ
J Manag Care Spec Pharm; 2019 Nov; 25(11):1185-1192. PubMed ID: 31663458
[TBL] [Abstract][Full Text] [Related]
36. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
37. Should cholesterol-lowering medications be available in Canada without a prescription?
Rashid S
Can J Cardiol; 2007 Mar; 23(3):189-93. PubMed ID: 17347688
[TBL] [Abstract][Full Text] [Related]
38. Looking at CER from the managed care organization perspective.
Cannon HE
J Manag Care Pharm; 2012 May; 18(4 Suppl A):S13-6. PubMed ID: 22578213
[TBL] [Abstract][Full Text] [Related]
39. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
Gurwitz JH; McLaughlin TJ; Fish LS
Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
[TBL] [Abstract][Full Text] [Related]
40. Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy.
2018-2019 Academy of Managed Care Pharmacy Professional Practice Committee
J Manag Care Spec Pharm; 2019 Jun; 25(6):641-644. PubMed ID: 30977701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
